Juan Domingo Gispert
Juan Domingo Gispert
Group Leader - Neuroimaging. Barcelonabeta Brain Research Center - Fundació Pasqual Maragall
Verified email at fpmaragall.org
Title
Cited by
Cited by
Year
β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
SP Tenbaum, P Ordóñez-Morán, I Puig, I Chicote, O Arqués, S Landolfi, ...
Nature medicine 18 (6), 892-901, 2012
3412012
Global and regional gray matter reductions in ADHD: a voxel-based morphometric study
S Carmona, O Vilarroya, A Bielsa, V Tremols, JC Soliva, M Rovira, ...
Neuroscience Letters 389 (2), 88-93, 2005
3262005
sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ...
EMBO molecular medicine 8 (5), 466-476, 2016
2622016
The expression of GLP‐1 receptor mRNA and protein allows the effect of GLP‐1 on glucose metabolism in the human hypothalamus and brainstem
E Alvarez, MD Martínez, I Roncero, JA Chowen, B García‐Cuartero, ...
Journal of neurochemistry 92 (4), 798-806, 2005
2322005
Imaging Brain Inflammation with [11C]PK11195 by PET and Induction of the Peripheral-Type Benzodiazepine Receptor after Transient Focal Ischemia in Rats
S Rojas, A Martín, MJ Arranz, D Pareto, J Purroy, E Verdaguer, J Llop, ...
Journal of Cerebral Blood Flow & Metabolism 27 (12), 1975-1986, 2007
1542007
Influence of the normalization template on the outcome of statistical parametric mapping of PET scans
JD Gispert, J Pascau, S Reig, R Martinez-Lazaro, V Molina, ...
Neuroimage 19 (3), 601-612, 2003
1482003
Ventro-striatal reductions underpin symptoms of hyperactivity and impulsivity in attention-deficit/hyperactivity disorder
S Carmona, E Proal, EA Hoekzema, JD Gispert, M Picado, I Moreno, ...
Biological psychiatry 66 (10), 972-977, 2009
1372009
Biodistribution of Amino-Functionalized Diamond Nanoparticles. In Vivo Studies Based on 18F Radionuclide Emission.
S Rojas, JD Gispert, R Martin, S Abad, C Mench n, D Pareto, VM V ctor, ...
ACS nano, 2011
1352011
Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia
V Molina, S Reig, J Sanz, T Palomo, C Benito, J Sánchez, F Sarramea, ...
Schizophrenia Research 80 (1), 61-71, 2005
1202005
Synthesis and In Vivo Evaluation of the Biodistribution of a 18F-Labeled Conjugate Gold-Nanoparticle-Peptide with Potential Biomedical Application
S Guerrero, JR Herance, S Rojas, JF Mena, JD Gispert, GA Acosta, ...
Bioconjugate chemistry 23 (3), 399-408, 2012
1052012
Pediatric OCD structural brain deficits in conflict monitoring circuits: a voxel-based morphometry study
S Carmona, N Bassas, M Rovira, JD Gispert, JC Soliva, M Prado, J Tomas, ...
Neuroscience Letters 421 (3), 218-223, 2007
962007
Method for bias field correction of brain T1‐weighted magnetic resonance images minimizing segmentation error
JD Gispert, S Reig, J Pascau, JJ Vaquero, P García‐Barreno, M Desco
Human brain mapping 22 (2), 133-144, 2004
892004
Enhanced neural activity in frontal and cerebellar circuits after cognitive training in children with attention‐deficit/hyperactivity disorder
E Hoekzema, S Carmona, V Tremols, JD Gispert, M Guitart, J Fauquet, ...
Human Brain Mapping 31 (12), 1942-1950, 2010
882010
Monitoring gene therapy by external imaging of mRNA: pilot study on murine erythropoietin
J Segura, C Fillat, D Andreu, J Llop, O Millan, BG de la Torre, Z Nikolovski, ...
Therapeutic drug monitoring 29 (5), 612, 2007
812007
The ALFA project: a research platform to identify early pathophysiological features of Alzheimer's disease
JL Molinuevo, N Gramunt, JD Gispert, K Fauria, M Esteller, C Minguillon, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 2 (2 …, 2016
782016
N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration
V Molina, J Sánchez, S Reig, J Sanz, C Benito, C Santamarta, J Pascau, ...
Schizophrenia research 73 (2-3), 209-219, 2005
712005
Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease
JD Gispert, M Suarez-Calvet, GC Monte, A Tucholka, C Falcon, S Rojas, ...
Alzheimer's & Dementia 12 (12), 1259-1272, 2016
682016
Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement
V Molina, JD Gispert, S Reig, J Sanz, J Pascau, A Santos, M Desco, ...
Psychopharmacology 178 (1), 17-26, 2005
682005
A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells
I Puig, I Chicote, SP Tenbaum, O Arqués, JR Herance, JD Gispert, ...
Clinical Cancer Research 19 (24), 6787-6801, 2013
672013
Cerebral metabolic patterns in chronic and recent-onset schizophrenia
M Desco, JD Gispert, S Reig, J Sanz, J Pascau, F Sarramea, C Benito, ...
Psychiatry Research: Neuroimaging 122 (2), 125-135, 2003
652003
The system can't perform the operation now. Try again later.
Articles 1–20